“sutro-biopharma” Archives

in
Entry Author Date Location
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Six Life Science Firms Close Q3 with an IPO, More Are on the Way 09/28/18 Boston
Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs 08/30/18 San Francisco
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
Celgene Narrows Its Relationship With Sutro, No Acquisition Coming 08/10/17 New York
Gener8tor, StartingBlock, Wicab, & More: This Week’s WI Watchlist 05/19/17 Wisconsin
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
Invenra Adds Partners, Still Open to Developing Own Drugs in Future 03/14/17 Wisconsin
West Coast Biotech Roundup: Hutch, Gilead, Soon-Shiong IPO & More 07/30/15 San Francisco
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Invenra Partners With U.K. Company to Research Therapeutic Antibodies 06/25/15 Wisconsin
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
Invenra Advancing Its Cell-Free Antibody Tech With $2M in New Cash 01/29/15 Wisconsin
NimbleGen Cofounder Opens Invenra, A “Cell-Free” Antibody Shop 11/05/14 Wisconsin
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
Navigating JOBS, Wrangling Investors: A Biotech CFO Roundtable 05/27/14 National
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Sutro Biopharma Garners $26,000,000 Series D Funding 12/11/13 San Francisco
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Page 1 of 2 next page »